These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35501101)

  • 21. "It's an emotional roller coaster… But sometimes it's fucking awesome": Meaning and motivation of work for peers in overdose response environments in British Columbia.
    Pauly BB; Mamdani Z; Mesley L; McKenzie S; Cameron F; Edwards D; Howell A; Knott M; Scott T; Seguin R; Greer AM; Buxton JA
    Int J Drug Policy; 2021 Feb; 88():103015. PubMed ID: 33176249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating opioid preference to inform safe supply services: A cross sectional study.
    Ferguson M; Parmar A; Papamihali K; Weng A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Mar; 101():103574. PubMed ID: 35007878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study.
    Ackermann E; Kievit B; Xavier J; Barbic S; Ferguson M; Greer A; Loyal J; Mamdani Z; Palis H; Pauly B; Slaunwhite A; Buxton JA
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):42. PubMed ID: 35614474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing trends and incidence of nonfatal overdose among women sex workers who use drugs in British Columbia: The role of criminalization-related barriers to harm reduction.
    Argento E; Shannon K; Fairbairn N; Moreheart S; Braschel M; Goldenberg S
    Drug Alcohol Depend; 2023 Mar; 244():109789. PubMed ID: 36753803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A qualitative assessment of tablet injectable opioid agonist therapy (TiOAT) in rural and smaller urban British Columbia, Canada: Motivations and initial impacts.
    Bowles J; Mansoor M; Werb D; Kerr T; Bardwell G
    J Subst Use Addict Treat; 2024 Feb; 157():209185. PubMed ID: 37865289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Awareness, predictors and outcomes of drug alerts among people who access harm reduction services in British Columbia, Canada: findings from a 2021 cross-sectional survey.
    Daowd K; Ferguson M; Liu L; Loyal J; Lock K; Graham B; Lamb J; McDougall J; Buxton JA
    BMJ Open; 2023 May; 13(5):e071379. PubMed ID: 37160395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Take-home drug checking as a novel harm reduction strategy in British Columbia, Canada.
    Klaire S; Janssen RM; Olson K; Bridgeman J; Korol EE; Chu T; Ghafari C; Sabeti S; Buxton JA; Lysyshyn M
    Int J Drug Policy; 2022 Aug; 106():103741. PubMed ID: 35671687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of drug overdoses and user characteristics of Canada's national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS).
    Viste D; Rioux W; Cristall N; Orr T; Taplay P; Morris-Miller L; Ghosh SM
    BMC Public Health; 2023 Sep; 23(1):1869. PubMed ID: 37752527
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Social network support and harm reduction activities in a peer researcher-led pilot study, British Columbia, Canada.
    Elkhalifa S; Jozaghi E; Marsh S; Thomson E; Gregg D; Buxton J; Jolly A
    Harm Reduct J; 2020 Aug; 17(1):57. PubMed ID: 32825836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opportunities and challenges for implementing drug checking services in British Columbia, Canada: A qualitative study.
    Chayama KL; Ti L; Arredondo Sanchez Lira J; Coulaud PJ; Bardwell G; Knight R
    Int J Drug Policy; 2024 Oct; 132():104560. PubMed ID: 39217815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of co-occurring mental illness and substance use disorder and association with overdose: a linked data cohort study among residents of British Columbia, Canada.
    Keen C; Kinner SA; Young JT; Jang K; Gan W; Samji H; Zhao B; Krausz M; Slaunwhite A
    Addiction; 2022 Jan; 117(1):129-140. PubMed ID: 34033179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study.
    Pauly BB; Kurz M; Dale LM; Macevicius C; Kalicum J; Pérez DG; McCall J; Urbanoski K; Barker B; Slaunwhite A; Lindsay M; Nosyk B
    J Subst Use Addict Treat; 2024 Jun; 161():209341. PubMed ID: 38490334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overdose Prevention and Housing: a Qualitative Study Examining Drug Use, Overdose Risk, and Access to Safer Supply in Permanent Supportive Housing in Vancouver, Canada.
    Ivsins A; MacKinnon L; Bowles JM; Slaunwhite A; Bardwell G
    J Urban Health; 2022 Oct; 99(5):855-864. PubMed ID: 36044156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic oxygen responses to smoking opioids: an observational study using continuous pulse oximetry at overdose prevention services in British Columbia, Canada.
    Moe J; Buxton JA; Wang YE; Chavez T; Feldman-Kiss D; Marr C; Purssell RA; Otterstatter M
    Harm Reduct J; 2024 May; 21(1):89. PubMed ID: 38702702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting.
    Tupper KW; McCrae K; Garber I; Lysyshyn M; Wood E
    Drug Alcohol Depend; 2018 Sep; 190():242-245. PubMed ID: 30064061
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opening Canada's first Health Canada-approved supervised consumption sites.
    Patterson T; Bharmal A; Padhi S; Buchner C; Gibson E; Lee V
    Can J Public Health; 2018 Aug; 109(4):581-584. PubMed ID: 30039262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards cross-Canada monitoring of the unregulated street drug supply.
    Biggar E; Papamihali K; Leclerc P; Hyshka E; Graham B; Taylor M; Payer D; Maloney-Hall B; Buxton JA
    BMC Public Health; 2021 Sep; 21(1):1678. PubMed ID: 34525994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing risk and presentation of overdose associated with consumption of street drugs at a supervised injection site in Vancouver, Canada.
    Notta D; Black B; Chu T; Joe R; Lysyshyn M
    Drug Alcohol Depend; 2019 Mar; 196():46-50. PubMed ID: 30665151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.